Cancer Research AACR Conference on Molecular Diagnostics - 2008  AACR Conference on Molecular Diagnostics - 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

[Cancer Research 52, 6945-6948, December 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shimizu, K.
Right arrow Articles by Ohki, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shimizu, K.
Right arrow Articles by Ohki, M.

Consistent Disruption of the AML1 Gene Occurs within a Single Intron in the t(8;21) Chromosomal Translocation1

Kimiko Shimizu2, Hiroyuki Miyoshi, Tomoko Kozu, Junko Nagata, Keiichiro Enomoto, Nobuo Maseki, Yasuhiko Kaneko and Misao Ohki

Department of Immunology and Virology, Saitama Cancer Center Research Institute [K. S., H. M., T. K., J. N., K. E., M. O.], and Department of Hematology Clinic [N. M.] and Department of Laboratory Medicine [Y. K.], Saitama Cancer Center Hospital, 818, Komura, Ina, Saitama 362, Japan

2 To whom requests for reprints should be addressed.

The AML1 gene on chromosome 21 was rearranged by the t(8;21) chromosomal translocation in acute myeloid leukemia (AML). Southern blot analysis of 21 AML patients with t(8;21), including three with complex translocations, t(8;V;21), demonstrated that all the breakpoints occurred at random within a single intron between two coding exons of AML1. Clustering of the breakpoints in the restricted intron suggests the formation of a unique fusion gene between the AML1 gene and a presumable counterpart gene on chromosome 8. Nucleotide sequencing of the breakpoint region revealed that the translocation event was accompanied by deletion of a short stretch of nucleotides.

1 Supported in part by a Grant-in-Aid for a Comprehensive 10-year Strategy for Cancer Control from the Ministry of Health and Welfare; a Grant-in-Aid for Creative Basic Research (Human Genome Program) from the Ministry of Education, Science, and Culture; and a grant of Special Co-ordination Funds for Promotion of Science and Technology from the Science and Technology Agency of Japan.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 9/10/92. Accepted 10/26/92.




This article has been cited by other articles:


Home page
DevelopmentHome page
J. Wildonger and R. S. Mann
The t(8;21) translocation converts AML1 into a constitutive transcriptional repressor
Development, May 15, 2005; 132(10): 2263 - 2272.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J. P. Huntly, A. Bench, and A. R. Green
Double jeopardy from a single translocation: deletions of the derivative chromosome 9 in chronic myeloid leukemia
Blood, August 15, 2003; 102(4): 1160 - 1168.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
B. J. P. Huntly, A. J. Bench, E. Delabesse, A. G. Reid, J. Li, M. A. Scott, L. Campbell, J. Byrne, E. Pinto, A. Brizard, et al.
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability
Blood, May 29, 2002; 99(12): 4547 - 4553.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Zhang, P. Strissel, R. Strick, J. Chen, G. Nucifora, M. M. Le Beau, R. A. Larson, and J. D. Rowley
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia
PNAS, February 20, 2002; (2002) 42702899.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Miyamoto, I. L. Weissman, and K. Akashi
AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation
PNAS, June 20, 2000; 97(13): 7521 - 7526.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. B. Sinclair, E. P. Nacheva, M. Leversha, N. Telford, J. Chang, A. Reid, A. Bench, K. Champion, B. Huntly, and A. R. Green
Large deletions at the t(9;22) breakpoint are common and may identify a poor-prognosis subgroup of patients with chronic myeloid leukemia
Blood, February 1, 2000; 95(3): 738 - 743.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Zhang, P. Strissel, R. Strick, J. Chen, G. Nucifora, M. M. Le Beau, R. A. Larson, and J. D. Rowley
Genomic DNA breakpoints in AML1/RUNX1 and ETO cluster with topoisomerase II DNA cleavage and DNase I hypersensitive sites in t(8;21) leukemia
PNAS, March 5, 2002; 99(5): 3070 - 3075.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1992 by the American Association for Cancer Research.